Found! Brain tumour culpritOctober 24th, 2011 - 12:10 pm ICT by IANS
Sydney, Oct 24 (IANS) Scientists have pinned down a culprit that allows brain tumours to survive and grow.
An international team identified the key role played by kynurenine, by-product of the metabolism of amino acid tryptophan, in brain tumour growth, the journal Nature reports.
The discovery offers hope of new drug treatment for gliomas — the most common and aggressive type of brain tumour in both adults and children. The survival time of patients is less than a year.
Gilles Guillemin, an associate professor with the University of New South Wales, said the breakthrough could potentially lead to viable therapeutics for a range of conditions.
These conditions include Alzheimer’s disease, motor neuron diseases, multiple sclerosis and Parkinson’s disease, according to a New South Wales statement.
An oral drug able to block enzymes leading to kynurenine production has been developed. It could potentially be available for clinical trials within a few years, Guillemin said.
- Scientists produce compound that may treat Parkinson's disease - Feb 12, 2011
- Potential therapeutic target for Parkinson's, Alzheimer's identified - Mar 12, 2011
- Tobacco-derived compound prevents memory loss in Alzheimer's - Apr 28, 2011
- Insulin could play powerful role in fighting Alzheimer's - Apr 02, 2011
- Wine could boost memory and learning ability - Jul 12, 2010
- Scientists eliminate plaque formation in Alzheimer's - Sep 06, 2012
- This substance tricks brain to ease Parkinson's - Apr 21, 2011
- A breakthrough in Alzhemier's or Parkinson's treatment? - May 07, 2012
- Delivering drugs directly to brain may help Alzheimer's sufferers - Mar 21, 2011
- How Alzheimer's plaques lead to loss of nitric oxide in brain - Jan 11, 2011
- Australia opens brain research centre - Oct 17, 2011
- Reduced levels of important neurotransmitter linked to multiple sclerosis - Feb 13, 2011
- What causes brain cell death in Parkinson's patients - Jan 08, 2011
- Alzheimer's drugs may have serious side-effects - Feb 20, 2012
- How misfolded protein spreads from cell to cell, potentially spreading disease - Feb 19, 2011
Tags: aggressive type, alzheimer, amino acid tryptophan, associate professor, brain tumour, brain tumours, clinical trials, culprit, enzymes, gilles, guillemin, journal nature, key role, metabolism, motor neuron diseases, multiple sclerosis, new south wales, oral drug, survival time, university of new south wales